New York, United States
NOVOS, founded in 2018, is a pioneering company in the Biotechnology and Health and Wellness sectors. The company's slogan, "Making the latest scientific advances in longevity accessible and achievable for all," underscores its mission to leverage cutting-edge science to produce nutraceuticals aimed at extending human lifespan. By focusing on the 12 mechanisms of aging, NOVOS claims to combine scientifically validated ingredients that potentially extend lifespan in various organisms.
The company's credibility is bolstered by an esteemed advisory team, including biochemists and geneticists from prestigious institutions like Harvard, MIT, and the University of Washington. Advisors have been recognized with awards such as the Breakthroughs in Gerontology and have been featured in notable publications. NOVOS operates as a Public Benefit Corporation, contributing a share of profits to nonprofits, enhancing its appeal to socially conscious investors.
The most recent financial injection, an Angel Round investment from Audrey Capital in January 2022, reflects continued investor confidence. With its headquarters in the United States, NOVOS positions itself as a leader in the evolving longevity market.
